APLS logo

Apellis Pharmaceuticals (APLS) Working Capital

Annual Working Capital

$518.74 M
-$33.17 M-6.01%

December 31, 2023


Summary


Performance

APLS Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAPLSbalance sheetmetrics:

Quarterly Working Capital

$642.64 M
-$48.17 M-6.97%

September 30, 2024


Summary


Performance

APLS Quarterly Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAPLSbalance sheetmetrics:

Working Capital Formula

Working Capital = Current Assets − Current Liabilities

APLS Working Capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-6.0%+23.9%
3 y3 years-34.2%-7.2%
5 y5 years+179.8%-7.2%

APLS Working Capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-25.1%at low-34.4%+23.9%
5 y5-year-34.2%+68.8%-34.4%+109.1%
alltimeall time-34.2%>+9999.0%-34.4%+5787.5%

Apellis Pharmaceuticals Working Capital History

DateAnnualQuarterly
Sep 2024
-
$642.64 M(-7.0%)
Jun 2024
-
$690.81 M(+15.9%)
Mar 2024
-
$596.14 M(+14.9%)
Dec 2023
$518.74 M(-6.0%)
$518.74 M(-15.1%)
Sep 2023
-
$611.14 M(-14.9%)
Jun 2023
-
$717.85 M(-12.0%)
Mar 2023
-
$815.61 M(+47.8%)
Dec 2022
$551.91 M(-20.3%)
$551.91 M(-23.0%)
Sep 2022
-
$716.49 M(-14.0%)
Jun 2022
-
$833.18 M(-14.9%)
Mar 2022
-
$979.21 M(+41.5%)
Dec 2021
$692.20 M(-12.3%)
$692.20 M(+81.6%)
Sep 2021
-
$381.19 M(-23.4%)
Jun 2021
-
$497.34 M(-27.9%)
Mar 2021
-
$689.96 M(-12.5%)
Dec 2020
$788.87 M
$788.87 M(+18.3%)
Sep 2020
-
$667.08 M(-16.2%)
Jun 2020
-
$795.84 M(+28.0%)
DateAnnualQuarterly
Mar 2020
-
$621.67 M(+102.3%)
Dec 2019
$307.34 M(+65.8%)
$307.34 M(-24.4%)
Sep 2019
-
$406.62 M(+49.0%)
Jun 2019
-
$272.82 M(-6.0%)
Mar 2019
-
$290.14 M(+56.5%)
Dec 2018
$185.41 M(+5.7%)
$185.41 M(-16.8%)
Sep 2018
-
$222.90 M(-13.1%)
Jun 2018
-
$256.45 M(+64.6%)
Mar 2018
-
$155.79 M(-11.2%)
Dec 2017
$175.46 M(+639.4%)
$175.46 M(+1350.7%)
Sep 2017
-
$12.10 M(-76.0%)
Jun 2017
-
$50.45 M(+112.6%)
Dec 2016
$23.73 M(-31.9%)
$23.73 M(-31.9%)
Dec 2015
$34.84 M(+164.7%)
$34.84 M(+219.2%)
Sep 2015
-
$10.92 M(-29.3%)
Jun 2015
-
$15.44 M(+17.3%)
Dec 2014
$13.17 M(+191.7%)
$13.17 M
Dec 2013
$4.51 M
-

FAQ

  • What is Apellis Pharmaceuticals annual working capital?
  • What is the all time high annual working capital for Apellis Pharmaceuticals?
  • What is Apellis Pharmaceuticals annual working capital year-on-year change?
  • What is Apellis Pharmaceuticals quarterly working capital?
  • What is the all time high quarterly working capital for Apellis Pharmaceuticals?
  • What is Apellis Pharmaceuticals quarterly working capital year-on-year change?

What is Apellis Pharmaceuticals annual working capital?

The current annual working capital of APLS is $518.74 M

What is the all time high annual working capital for Apellis Pharmaceuticals?

Apellis Pharmaceuticals all-time high annual working capital is $788.87 M

What is Apellis Pharmaceuticals annual working capital year-on-year change?

Over the past year, APLS annual working capital has changed by -$33.17 M (-6.01%)

What is Apellis Pharmaceuticals quarterly working capital?

The current quarterly working capital of APLS is $642.64 M

What is the all time high quarterly working capital for Apellis Pharmaceuticals?

Apellis Pharmaceuticals all-time high quarterly working capital is $979.21 M

What is Apellis Pharmaceuticals quarterly working capital year-on-year change?

Over the past year, APLS quarterly working capital has changed by +$123.90 M (+23.88%)